Healthcare -
Biotechnology - NASDAQ - US
$ 4.125
-2.6 %
$ 1.35 B
Market Cap
-3.22
P/E
IOVA - OTHER LONG-TERM ASSETS
Other Long-term Assets IOVA - Iovance Biotherapeutics, Inc.
66.7 M
LAST VALUE
191.16%
2 YEAR CAGR
89.02%
5 YEAR CAGR
0.00%
10 YEAR CAGR